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In order to adapt to changes in environmental osmolarity cells initiate massive 
transcriptional changes. In D. discoideum, STATc (Signal Transducer and Activator of 
Transcription c) is a key regulator of the transcriptional response to hyperosmotic 
stress. Under this condition, STATc is phosphorylated on Tyr922, dimerises, and 
translocates to the nucleus, where it controls gene expression. In mammals, STATs 
are activated by JAKs (Janus kinases), however, D. discoideum does not encode 
bona fide tyrosine kinases and there is no JAK ortholog. Recent work revealed two 
direct STATc regulators, PTP3 (Protein Tyrosine Phosphatase 3) and Pyk2 
(tyrosine-kinase like, TKL protein) (Araki et al., 2008; Araki et al., 2012). However, 
STATc was still phosphorylated in a pyk2- strain, albeit with reduced efficiency.  
Based on microarray studies, we chose three TKL proteins, Pyk3, Phg2, and MORN, 
as possible STATc protein kinase candidates. We analysed single knock-out mutants 
for these genes, a double knock-out mutant for Pyk3 and Phg2, as well as 
STATc-GFP overexpressing Ax2 wild-type and mutant cells with respect to 
transcriptional regulation, STATc phosphorylation, and nuclear translocation. 
Transcriptional regulation of STATc and STATc dependent genes was disturbed in 
pyk3-, phg2-, MORN-, and pyk3-/phg2- cells. The absence of Pyk3 resulted in 
significantly reduced and of Phg2 in completely abolished transcriptional activation of 
these genes in response to sorbitol and 8-Bromo cGMP. Phospho-STATc levels upon 
sorbitol and 8-Bromo cGMP treatment were significantly reduced in pyk3- and phg2- 
cells and further decreased in pyk3-/phg2- cells. This result was reflected by delayed 
nuclear translocation of GFP-STATc in these strains. Furthermore, overexpression of 
Pyk3 led to constitutive STATc phosphorylation and Pyk3 directly phosphorylated 
bacterially expressed STATc in vitro. To further analyse Phg2 Myc-Phg2 
overexpressing Ax2 wild-type cells and Myc-PTP3 overexpressing Ax2 wild-type and 
phg2- cells were generated. By using PTP3 phosphoserine-specific antibodies we 
found that Phg2 is involved in the inhibition and phosphorylation of PTP3 on S747. 
Pull-down assays suggest a direct interaction between Phg2 and PTP3.  
In response to hyperosmotic conditions, a bifurcated signaling pathway controls the 
activity of STATc. In the cGMP-dependent branch, Pyk3 directly phosphorylates 
STATc and Phg2 possibly PTP3 on S747. In the Ca2+-dependent branch, Pyk2 is the 
STATc kinase and we postulate a further protein kinase that phosphorylates PTP3 on 
S448. This complex regulation ascertains optimal STATc activation. 
